Biopharmaceuticals Contract Manufacturing Market Worth $21.7 Billion by 2025: Grand View Research, Inc.

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion by 2025,…

Micro Interventional Devices, Inc.(TM) Announces Continued Successful Enrollment in STTAR Trial

NEWTOWN, Pa., Nov. 29, 2018 /PRNewswire/ — Micro Interventional Devices, Inc.™ (MID) announced the continued successful enrollment…

Kali Inc Acquires Patented Cannabis Extraction Operation Entering $50 Billion Pharmaceutical Market and $8 Billion Concentrates Market

Kali, Inc. (USOTC: KALY) today announced finalizing the acquisition of NCM Biotech.  NCM Biotech is the…

New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency

Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the…

Protein Expression Market to be Driven by Rising Protein and Biologics Production Till 2025 | Million Insights

The global Protein Expression Market is anticipated to grow at a CAGR of 10.4% by 2025…

Ozempic® Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline

‘Cardiovascular disease remains the leading cause of disability and death in people with type 2 diabetes…

Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce…

Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, provides the following update…

PharmaMar Announces Participation at the 17th Needham & Co Annual Healthcare Conference in New York City

PharmaMar (MCE: PHM), today announced it will be featured as a presenting company at the 17th…

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi